Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density

Berenice Y. Reed, William L. Gitomer, Howard J. Heller, Chue Hsu Ming, Martha Lemke, Paulette Padalino, Charles Y C Pak

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Absorptive hypercalciuria (AH) is a kidney stone-forming condition frequently complicated by bone loss. Previously, we mapped the locus for an inherited form of AH to chromosome 1q23.3-q24. We have sequenced a putative gene (subsequently shown by others to be homologous with the rat soluble adenylate cyclase gene) in this region in 12 unrelated Caucasian AH patients. Eighteen base substitutions were identified in the soluble adenylate cyclase human homolog gene. All sequence variations were further evaluated in 3-68 additional unrelated AH patients and 19-132 normal subjects, and 1 additional base substitution was identified. Six of the identified sequence variations occurred with increased frequency in the AH population and tracked with the AH phenotype in AH families. Calculated odds ratios showed that the occurrence of any 4 of these individual base substitutions was associated with a 2.2- to 3.5-fold increase in estimated risk for AH (P < 0.02). In addition, 1 or more base changes was associated with a lower L2-L4 vertebral bone density. Sequence analysis of 3 other genes within the AH linkage interval showed no difference in the distribution of sequence variations between AH and normal populations. This is the first description of a specific gene defect associated with AH.

Original languageEnglish (US)
Pages (from-to)1476-1485
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume87
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Hypercalciuria
Bone Density
Bone
Substitution reactions
Genes
Phenotype
Chromosomes
Adenylyl Cyclases
Rats
Defects
Kidney Calculi
Population
Sequence Analysis
Odds Ratio

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. / Reed, Berenice Y.; Gitomer, William L.; Heller, Howard J.; Ming, Chue Hsu; Lemke, Martha; Padalino, Paulette; Pak, Charles Y C.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 87, No. 4, 2002, p. 1476-1485.

Research output: Contribution to journalArticle

Reed, Berenice Y. ; Gitomer, William L. ; Heller, Howard J. ; Ming, Chue Hsu ; Lemke, Martha ; Padalino, Paulette ; Pak, Charles Y C. / Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. In: Journal of Clinical Endocrinology and Metabolism. 2002 ; Vol. 87, No. 4. pp. 1476-1485.
@article{91c22658774643868f9050d0b18707d8,
title = "Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density",
abstract = "Absorptive hypercalciuria (AH) is a kidney stone-forming condition frequently complicated by bone loss. Previously, we mapped the locus for an inherited form of AH to chromosome 1q23.3-q24. We have sequenced a putative gene (subsequently shown by others to be homologous with the rat soluble adenylate cyclase gene) in this region in 12 unrelated Caucasian AH patients. Eighteen base substitutions were identified in the soluble adenylate cyclase human homolog gene. All sequence variations were further evaluated in 3-68 additional unrelated AH patients and 19-132 normal subjects, and 1 additional base substitution was identified. Six of the identified sequence variations occurred with increased frequency in the AH population and tracked with the AH phenotype in AH families. Calculated odds ratios showed that the occurrence of any 4 of these individual base substitutions was associated with a 2.2- to 3.5-fold increase in estimated risk for AH (P < 0.02). In addition, 1 or more base changes was associated with a lower L2-L4 vertebral bone density. Sequence analysis of 3 other genes within the AH linkage interval showed no difference in the distribution of sequence variations between AH and normal populations. This is the first description of a specific gene defect associated with AH.",
author = "Reed, {Berenice Y.} and Gitomer, {William L.} and Heller, {Howard J.} and Ming, {Chue Hsu} and Martha Lemke and Paulette Padalino and Pak, {Charles Y C}",
year = "2002",
doi = "10.1210/jc.87.4.1476",
language = "English (US)",
volume = "87",
pages = "1476--1485",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density

AU - Reed, Berenice Y.

AU - Gitomer, William L.

AU - Heller, Howard J.

AU - Ming, Chue Hsu

AU - Lemke, Martha

AU - Padalino, Paulette

AU - Pak, Charles Y C

PY - 2002

Y1 - 2002

N2 - Absorptive hypercalciuria (AH) is a kidney stone-forming condition frequently complicated by bone loss. Previously, we mapped the locus for an inherited form of AH to chromosome 1q23.3-q24. We have sequenced a putative gene (subsequently shown by others to be homologous with the rat soluble adenylate cyclase gene) in this region in 12 unrelated Caucasian AH patients. Eighteen base substitutions were identified in the soluble adenylate cyclase human homolog gene. All sequence variations were further evaluated in 3-68 additional unrelated AH patients and 19-132 normal subjects, and 1 additional base substitution was identified. Six of the identified sequence variations occurred with increased frequency in the AH population and tracked with the AH phenotype in AH families. Calculated odds ratios showed that the occurrence of any 4 of these individual base substitutions was associated with a 2.2- to 3.5-fold increase in estimated risk for AH (P < 0.02). In addition, 1 or more base changes was associated with a lower L2-L4 vertebral bone density. Sequence analysis of 3 other genes within the AH linkage interval showed no difference in the distribution of sequence variations between AH and normal populations. This is the first description of a specific gene defect associated with AH.

AB - Absorptive hypercalciuria (AH) is a kidney stone-forming condition frequently complicated by bone loss. Previously, we mapped the locus for an inherited form of AH to chromosome 1q23.3-q24. We have sequenced a putative gene (subsequently shown by others to be homologous with the rat soluble adenylate cyclase gene) in this region in 12 unrelated Caucasian AH patients. Eighteen base substitutions were identified in the soluble adenylate cyclase human homolog gene. All sequence variations were further evaluated in 3-68 additional unrelated AH patients and 19-132 normal subjects, and 1 additional base substitution was identified. Six of the identified sequence variations occurred with increased frequency in the AH population and tracked with the AH phenotype in AH families. Calculated odds ratios showed that the occurrence of any 4 of these individual base substitutions was associated with a 2.2- to 3.5-fold increase in estimated risk for AH (P < 0.02). In addition, 1 or more base changes was associated with a lower L2-L4 vertebral bone density. Sequence analysis of 3 other genes within the AH linkage interval showed no difference in the distribution of sequence variations between AH and normal populations. This is the first description of a specific gene defect associated with AH.

UR - http://www.scopus.com/inward/record.url?scp=0036281208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036281208&partnerID=8YFLogxK

U2 - 10.1210/jc.87.4.1476

DO - 10.1210/jc.87.4.1476

M3 - Article

C2 - 11932268

AN - SCOPUS:0036281208

VL - 87

SP - 1476

EP - 1485

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -